Back to Results
First PageMeta Content



Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products — General Considerations U.S. Department of Health and Human Services
Add to Reading List

Document Date: 2016-10-10 11:03:21


Open Document

File Size: 394,74 KB

Share Result on Facebook